TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF MIDDLE EAST & AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES, SOFTWARE MARKET 17
1.4 CURRENCY AND PRICING 18
1.5 LIMITATION 18
1.6 MARKETS COVERED 18
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 YEARS CONSIDERED FOR THE STUDY 21
2.3 CURRENCY AND PRICING 21
2.4 RESEARCH METHODOLOGY 22
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 25
2.6 SECONDARY SOURCES 26
2.7 ASSUMPTIONS 27
3 MARKET OVERVIEW 28
3.1 DRIVERS 30
3.1.1 INCREASE IN NUMBER OF CHRONIC DISEASES 30
3.1.2 INCREASING DEMAND OF AMBULATORY INFUSION DEVICES 30
3.1.3 INCREASING GERIATRIC POPULATION 30
3.1.4 TECHNOLOGICAL ADVANCEMENTS 31
3.1.5 INCREASE IN NUMBER OF SURGERIES PERFORMED 31
3.2 RESTRAINTS 32
3.2.1 PRODUCT RECALLS 32
3.2.2 STRINGENT REGULATIONS 32
3.2.3 INCREASE IN ACCEPTANCE OF REFURBISHED AND REUSED PRODUCTS 32
3.3 OPPORTUNITIES 33
3.3.1 EMERGING MARKETS 33
3.3.2 GOVERNMENT INITITAVIES TO REDUCE HEALTHCARE EXPENDITURE 33
3.4 CHALLENGES 35
3.4.1 INCREASE IN HUMAN ERRORS AND LACK OF WIRELESS CONNECTIVITY IN HOSPITALS 35
3.4.2 DEFECTS IN SOFTWARE 35
4 EXECUTIVE SUMMARY 36
5 PREMIUM INSIGHTS 38
6 MIDDLE EAST & AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES AND SOFTWARE MARKET, BY TYPE 39
6.1 OVERVIEW 40
6.2 INFUSION PUMP SYSTEMS 41
6.2.1 VOLUMETRIC INFUSION PUMP SYSTEM 41
6.2.2 AMBULATORY INFUSION PUMP SYSTEM 41
6.2.3 SYRINGE INFUSION PUMP SYSTEM 41
6.2.4 INSULIN INFUSION PUMP SYSTEM 41
6.2.5 ANESTHESIA INFUSION PUMP SYSTEM 41
6.2.6 CHEMOTHERAPY INFUSION PUMP SYSTEM 41
6.2.7 PATIENT- CONTROLLED ANALGESIC 42
6.2.8 ENTERAL INFUSION-PUMP SYSTEM 42
6.2.9 IMPLANTABLE- INFUSION PUMP SYSTEM 42
6.3 INFUSION PUMP ACCESSORIES 43
6.3.1 NEEDLESS CONNECTORS 43
6.3.2 INFUSION ADMINISTRATION SETS 43
6.3.3 IV SETS 43
6.4 INFUSION PUMP MANAGEMENT SOFTWARES 44
6.4.1 ELECTRONIC MEDICAL RECORDS (EMR) MODULES 44
6.4.2 RESPIRATORY MONITORING MODULES 44
6.4.3 ASSETS MANAGEMENT MODULES 44
7 MIDDLE EAST AND AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES AND SOFTWARE MARKET, BY APPLICATION 45
7.1 OVERVIEW 46
7.1.1 GENERAL INFUSION 47
7.1.2 INSULIN INFUSION 47
7.1.3 PAIN AND ANESTHESIA MANAGEMENT 47
7.1.4 CHEMOTHERAPY INFUSION 47
7.1.5 ENTERAL INFUSION 47
7.1.6 OTHERS 47
8 MIDDLE EAST & AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES AND SOFTWARE MARKET, BY END USER 48
8.1 OVERVIEW 49
8.2 HOSPITALS AND CLINICS 50
8.3 HOME HEALTHCARE 50
8.4 AMBULATORY CENTRES 50
9 MIDDLE EAST& AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES AND SOFTWARE MARKET, BY DISTRIBUTION CHANNEL 51
9.1 OVERVIEW 52
9.1.1 PUBLIC 53
9.1.2 PRIVATE 53
10 MIDDLE EAST& AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES AND SOFTWARE MARKET, BY GEOGRAPHY 54
10.1 SOUTH AFRICA 61
10.2 UAE 64
10.3 SAUDI ARABIA 67
10.4 QATAR 70
10.5 KUWAIT 73
10.6 EGYPT 76
10.7 BAHRAIN 79
10.8 OMAN 82
10.9 LEBANON 85
10.10 JORDAN 88
10.11 ALGERIA 91
10.12 TUNISIA 94
10.13 MOROCCO 97
10.14 NORTH AFRICA 100
10.15 REST OF MIDDLE EAST & AFRICA 103
11 MIDDLE EAST & AFRICA INFUSION PUMP SYSTEMS, ACCESSORIES, SOFTWARE MARKET, COMPANY LANDSCAPE 104
11.1 COMPANY SHARE ANALYSIS; MIDDLE EAST & AFRICA 104
?
12 COMPANY PROFILE 105
12.1 AVANOS CORPORATE 105
12.1.1 COMPANY OVERVIEW 105
12.1.2 REVENUE ANALYSIS 105
12.1.3 PRODUCT PORTFOLIO 106
12.1.4 RECENT DEVELOPMENTS 107
12.2 BAXTER 108
12.2.1 COMPANY OVERVIEW 108
12.2.2 REVENUE ANALYSIS 108
12.2.3 PRODUCT PORTFOLIO 109
12.2.4 RECENT DEVELOPMENTS 110
12.3 B.BRAUN MELSUNGEN AG 111
12.3.1 COMPANY OVERVIEW 111
12.3.2 REVENUE ANALYSIS 111
12.3.3 PRODUCT PORTFOLIO 112
12.3.4 RECENT DEVELOPMENTS 116
12.4 BD. 117
12.4.1 COMPANY OVERVIEW 117
12.4.2 REVENUE ANALYSIS 117
12.4.3 PRODUCT PORTFOLIO 118
12.4.4 RECENT DEVELOPMENTS 120
12.5 LIFESCAN, INC. 121
12.5.1 COMPANY SNAPSHOT 121
12.5.2 GEOGRAPHIC PRESENCE 121
12.5.3 PRODUCT PORTFOLIO 122
12.5.4 RECENT DEVELOPMENTS 122
12.6 MEDTRONIC 123
12.6.1 COMPANY OVERVIEW 123
12.6.2 REVENUE ANALYSIS 123
12.6.3 PRODUCT PORTFOLIO 124
12.6.4 RECENT DEVELOPMENTS 125
12.7 MICREL 126
12.7.1 COMPANY SNAPSHOT 126
12.7.2 GEOGRAPHIC PRESENCE 126
12.7.3 PRODUCT PORTFOLIO 127
12.7.4 RECENT DEVELOPMENTS 127
12.8 MOOG INC. 128
12.8.1 COMPANY OVERVIEW 128
12.8.2 REVENUE ANALYSIS 128
12.8.3 PRODUCT PORTFOLIO 129
12.8.4 RECENT DEVELOPMENTS 129
12.9 TERUMO CORPORATION 130
12.9.1 COMPANY OVERVIEW 130
12.9.2 REVENUE ANALYSIS 130
12.9.3 PRODUCT PORTFOLIO 131
12.9.4 RECENT DEVELOPMENTS 131
12.10 ZOLL MEDICAL CORPORATION (A SUBSIDARY OF ASAHI KASEI CORPORATION) 132
12.10.1 COMPANY OVERVIEW 132
12.10.2 GEOGRAPHIC PRESENCE 132
12.10.3 PRODUCT PORTFOLIO 133
12.10.4 RECENT DEVELOPMENT 133
13 RELATED REPORTS 134